The Impact of IDH1 Mutation and MGMT Promoter Methylation on Recurrence-Free Interval in Glioblastoma Patients Treated With Radiotherapy and Chemotherapeutic Agents

The aim of this study is to investigate the relationship between isocitrate dehydrogenase-1 (IDH1) mutation and O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation with recurrence-free interval in glioblastoma patients treated with chemoradiotherapies. Clinical data were collected f...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurdi, Maher, Shafique Butt, Nadeem, Baeesa, Saleh, Alghamdi, Badrah, Maghrabi, Yazid, Bardeesi, Anas, Saeedi, Rothaina, Al-Sinani, Taghreed, Alghanmi, Najla, Bari, Mohammed O., Samkari, Alaa, Lary, Ahmed I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Society Journal Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262235/
https://www.ncbi.nlm.nih.gov/pubmed/34257620
http://dx.doi.org/10.3389/pore.2021.1609778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262235/
https://www.ncbi.nlm.nih.gov/pubmed/34257620
http://dx.doi.org/10.3389/pore.2021.1609778

Ejemplares similares